Unknown

Dataset Information

0

Safety evaluation of the food enzyme endo-1,4-?-xylanase from a genetically modified Aspergillus oryzae (strain NZYM-FA).


ABSTRACT: The food enzyme is an endo-1,4-?-xylanase (EC 3.2.1.8) produced with a genetically modified strain of Aspergillus oryzae by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and recombinant DNA. This xylanase is intended to be used in baking and cereal-based processes. Based on the proposed maximum use levels, dietary exposure to the food enzyme-total organic solids (TOS) was estimated to be up to 0.027 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not raise a safety concern. Subchronic toxicity was assessed by means of a repeated dose 90-day oral toxicity study in rats. In this study, effects were seen in the control group on reproductive parameters (particularly the seminiferous epithelium atrophy in the testes) at incidences that far exceeded the background range. Consequently, a combined repeated dose toxicity study with the reproduction/developmental toxicity screening test, including haematological parameters and the immunology cohort, was conducted. The Panel identified a no observed adverse effect level at the highest dose tested of 1,101.3 mg TOS/kg bw per day. When compared with the dietary exposure, resulted in a sufficiently high margin of exposure (at least 40,000). Similarity of the amino acid sequence to those of known allergens was searched and no match was found. The Panel considered that under the intended conditions of use the risk for allergic sensitisation and elicitation reactions by dietary exposure cannot be excluded, but the likelihood is considered low. Based on the data provided, the Panel concluded that this food enzyme does not raise safety concerns under the intended conditions of use.

SUBMITTER: EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP) 

PROVIDER: S-EPMC7009587 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Safety evaluation of the food enzyme endo-1,4-β-xylanase from a genetically modified <i>Aspergillus oryzae</i> (strain NZYM-FA).

Silano Vittorio V   Barat Baviera José Manuel JM   Bolognesi Claudia C   Brüschweiler Beat Johannes BJ   Cocconcelli Pier Sandro PS   Crebelli Riccardo R   Gott David Michael DM   Grob Konrad K   Lampi Evgenia E   Mortensen Alicja A   Riviere Gilles G   Steffensen Inger-Lise IL   Tlustos Christina C   Van Loveren Henk H   Vernis Laurence L   Zorn Holger H   Glandorf Boet B   Herman Lieve L   Kärenlampi Sirpa S   Penninks André A   Željeżić Davor D   Aguilera-Gómez Margarita M   Andryszkiewicz Magdalena M   Arcella Davide D   Kovalkovičová Natália N   Liu Yi Y   Roncancio Peña Claudia C   Horn Christine C   Chesson Andrew A  

EFSA journal. European Food Safety Authority 20181116 11


The food enzyme is an endo-1,4-β-xylanase (EC 3.2.1.8) produced with a genetically modified strain of <i>Aspergillus oryzae</i> by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and recombinant DNA. This xylanase is intended to be used in baking and cereal-based processes. Based on the proposed maximum use levels, dietary exposure to the food enzyme-total organic solids (TOS) was estimated to be u  ...[more]

Similar Datasets

| S-EPMC7009475 | biostudies-literature